Multilayer Silicon Carbide Composite Material Technology for High-Temperature Concentrated Solar-Thermal Power Components

In 2012, the U.S Department of Energy defined aggressive targets to achieve lower component costs and higher system efficiencies for concentrated solar-thermal power (CSP), and this, in turn, has led to the exploration of technology options that can operate at higher temperatures [1]. These next-generation CSP options, referred to as Generation 3 (a.k.a. Gen3), are targeting temperatures at or above 700 oC for the energy being delivered to the power cycle, and the more challenging plant conditions have necessitated a review and selection of alternative receiver heat transfer fluids as well as a search for materials that can meet the associated high-temperature component requirements. Nickel-based alloys are currently being considered, but these generally experience a significant drop in strength at temperatures > 775 ºC [2] and may not be able to achieve corrosion and other lifetime requirements. Furthermore, these alloys are expensive, frequently have cost and schedule volatility, and offer little potential for lower cost at high production volumes. As an alternative, Ceramic Tubular Products, LLC (CTP) has developed a multilayer silicon carbide composite that can complement or replace alloys currently being considered for these Gen3 CSP applications

Multilayer Silicon Carbide Composite Material Technology for High-Temperature Concentrated Solar-Thermal Power Components

In 2012, the U.S Department of Energy defined aggressive targets to achieve lower component costs and higher system efficiencies for concentrated solar-thermal power (CSP), and this, in turn, has led to the exploration of technology options that can operate at higher temperatures [1]. These next-generation CSP options, referred to as Generation 3 (a.k.a. Gen3), are targeting temperatures at or above 700 oC for the energy being delivered to the power cycle, and the more challenging plant conditions have necessitated a review and selection of alternative receiver heat transfer fluids as well as a search for materials that can meet the associated high-temperature component requirements. Nickel-based alloys are currently being considered, but these generally experience a significant drop in strength at temperatures > 775 ºC [2] and may not be able to achieve corrosion and other lifetime requirements. Furthermore, these alloys are expensive, frequently have cost and schedule volatility, and offer little potential for lower cost at high production volumes. As an alternative, Ceramic Tubular Products, LLC (CTP) has developed a multilayer silicon carbide composite that can complement or replace alloys currently being considered for these Gen3 CSP applications

Comparing and Combining Capillary Electrophoresis Electrospray Ionization Mass Spectrometry and Nano-Liquid Chromatography Electrospray Ionization Mass Spectrometry for the Characterization of Post-translationally Modified Histones

We present the first comprehensive capillary electrophoresis electrospray ionization mass spectrometry (CESI-MS) analysis of post-translational modifications derived from H1 and core histones. Using a capillary electrophoresis system equipped with a sheathless high-sensitivity porous sprayer and nano–liquid chromatography electrospray ionization mass spectrometry (nano-LC-ESI-MS) as two complementary techniques, we characterized H1 histones isolated from rat testis. Without any pre-separation of the perchloric acid extraction, a total of 70 different modified peptides, including 50 phosphopeptides, were identified in the rat linker histones H1.0, H1a-H1e, and H1t. Out of the 70 modified H1 histone peptides, 27 peptides could be identified with CESI-MS only, and 11 solely with LC-ESI-MS. Immobilized metal-affinity chromatography enrichment prior to MS analysis yielded a total of 55 phosphopeptides; 22 of these peptides could be identified only by CESI-MS, and 19 only by LC-ESI-MS, showing the complementarity of the two techniques. We mapped 42 H1 modification sites, including 31 phosphorylation sites, of which 8 were novel sites. For the analysis of core histones, we chose a different strategy. In a first step, the sulfuric-acid-extracted core histones were pre-separated using reverse-phase high-performance liquid chromatography. Individual rat testis core histone fractions obtained in this way were digested and analyzed via bottom-up CESI-MS. This approach yielded the identification of 42 different modification sites including acetylation (lysine and N(α)-terminal); mono-, di-, and trimethylation; and phosphorylation. When we applied CESI-MS for the analysis of intact core histone subtypes from butyrate-treated mouse tumor cells, we were able to rapidly detect their degree of modification, and we found this method very useful for the separation of isobaric trimethyl and acetyl modifications. Taken together, our results highlight the need for additional techniques for the comprehensive analysis of post-translational modifications. CESI-MS is a promising new proteomics tool as demonstrated by this, the first comprehensive analysis of histone modifications, using rat testis as an example

Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro–B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure

Abstract BACKGROUND Currently, N-terminal pro–B-type natriuretic peptide (NT-proBNP) and its physiologically active counterpart, BNP, are most frequently used as biomarkers for diagnosis, prognosis, and disease monitoring of heart failure (HF). Commercial NT-proBNP and BNP immunoassays cross-react to varying degrees with unprocessed proBNP, which is also found in the circulation. ProBNP processing and immunoassay response are related to O-linked glycosylation of NT-proBNP and proBNP. There is a clear and urgent need to identify the glycosylation sites in the endogenously circulating peptides requested by the community to gain further insights into the different naturally occurring forms. METHODS The glycosylation sites of (NT-) proBNP (NT-proBNP and/or proBNP) were characterized in leftovers of heparinized plasma samples of severe HF patients (NT-proBNP: &amp;gt;10000 ng/L) by using tandem immunoaffinity purification, sequential exoglycosidase treatment for glycan trimming, β-elimination and Michael addition chemistry, as well as high-resolution nano-flow liquid chromatography electrospray multistage mass spectrometry. RESULTS We describe 9 distinct glycosylation sites on circulating (NT-) proBNP in HF patients. Differentially glycosylated variants were detected based on highly accurate mass determination and multistage mass spectrometry. Remarkably, for each of the identified proteolytic glycopeptides, a nonglycosylated form also was detectable. CONCLUSIONS Our results directly demonstrate for the first time a rather complex distribution of the endogenously circulating glycoforms by mass spectrometric analysis in HF patients, and show 9 glycosites in human (NT-) proBNP. This information may also have an impact on commercial immunoassays applying antibodies specific for the central region of (NT-) proBNP, which detect mostly nonglycosylated forms. </jats:sec